These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 16336328

  • 1. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 2. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 3. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P, Katcher J, Levin H, Zippe C, Klein E.
    Urology; 1996 Aug 01; 48(2):249-60. PubMed ID: 8753737
    [Abstract] [Full Text] [Related]

  • 4. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun 01; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 5. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB, Zerbib M, Mejean A, Rouach Y, Debre B, Peyromaure M.
    Can J Urol; 2009 Oct 01; 16(5):4813-9. PubMed ID: 19796456
    [Abstract] [Full Text] [Related]

  • 6. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.
    J Urol; 2003 Feb 01; 169(2):517-23. PubMed ID: 12544300
    [Abstract] [Full Text] [Related]

  • 7. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2000 Nov 01; 164(5):1596-600. PubMed ID: 11025712
    [Abstract] [Full Text] [Related]

  • 8. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.
    Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML.
    BJU Int; 2008 Feb 01; 101(3):299-304. PubMed ID: 17922854
    [Abstract] [Full Text] [Related]

  • 9. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H.
    Mayo Clin Proc; 2001 Jun 01; 76(6):576-81. PubMed ID: 11393495
    [Abstract] [Full Text] [Related]

  • 10. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
    Rogers CG, Khan MA, Craig Miller M, Veltri RW, Partin AW.
    Cancer; 2004 Dec 01; 101(11):2549-56. PubMed ID: 15470681
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
    Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H.
    J Urol; 2003 Nov 01; 170(5):1872-6. PubMed ID: 14532796
    [Abstract] [Full Text] [Related]

  • 14. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
    Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M.
    BJU Int; 2008 Nov 01; 102(10):1413-8. PubMed ID: 18537951
    [Abstract] [Full Text] [Related]

  • 15. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul 01; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 16. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?
    Jones TD, Koch MO, Bunde PJ, Cheng L.
    BJU Int; 2006 Mar 01; 97(3):480-4. PubMed ID: 16469012
    [Abstract] [Full Text] [Related]

  • 17. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [Abstract] [Full Text] [Related]

  • 18. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
    Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.
    Urology; 2004 Oct 01; 64(4):723-8. PubMed ID: 15491709
    [Abstract] [Full Text] [Related]

  • 19. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec 01; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 20. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group.
    J Urol; 2003 Jun 01; 169(6):2136-41. PubMed ID: 12771735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.